[HTML][HTML] Emerging roles of cystathionine β-synthase in various forms of cancer
K Ascenção, C Szabo - Redox biology, 2022 - Elsevier
The expression of the reverse transsulfuration enzyme cystathionine-β-synthase (CBS) is
markedly increased in many forms of cancer, including colorectal, ovarian, lung, breast and …
markedly increased in many forms of cancer, including colorectal, ovarian, lung, breast and …
[HTML][HTML] The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy
B Hou, T Chen, H Zhang, J Li, P Wang… - Frontiers in …, 2023 - frontiersin.org
The tumor microenvironment (TME) is the tumor surrounding environment, which is critical
for tumor development and progression. TME is also involved in clinical intervention and …
for tumor development and progression. TME is also involved in clinical intervention and …
[HTML][HTML] Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis
IS Fetahu, W Esser-Skala, R Dnyansagar… - Nature …, 2023 - nature.com
Metastasis is the major cause of cancer-related deaths. Neuroblastoma (NB), a childhood
tumor has been molecularly defined at the primary cancer site, however, the bone marrow …
tumor has been molecularly defined at the primary cancer site, however, the bone marrow …
[HTML][HTML] Targeting KRAS in colorectal cancer: a bench to bedside review
Colorectal cancer (CRC) is a heterogeneous disease with a myriad of alterations at the
cellular and molecular levels. Kristen rat sarcoma (KRAS) mutations occur in up to 40% of …
cellular and molecular levels. Kristen rat sarcoma (KRAS) mutations occur in up to 40% of …
Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations
Q He, M Qu, H Bao, Y Xu, T Shen, D Tan… - Cytokine & Growth …, 2023 - Elsevier
Epidermal growth factor receptor (EGFR) mutation is the most common driver mutation in
non-small cell lung cancer (NSCLC). The first-line therapy for advanced NSCLC patients …
non-small cell lung cancer (NSCLC). The first-line therapy for advanced NSCLC patients …
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
X Luo, X He, X Zhang, X Zhao, Y Zhang, Y Shi… - MedComm, 2024 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a high
mortality rate. It is regarded as a significant public health issue because of its complicated …
mortality rate. It is regarded as a significant public health issue because of its complicated …
[HTML][HTML] MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
J Matuszyk - Molecular Medicine, 2022 - Springer
Background The active metabolite of 5-Fluorouracil (5FU), used in the treatment of several
types of cancer, acts by inhibiting the thymidylate synthase encoded by the TYMS gene …
types of cancer, acts by inhibiting the thymidylate synthase encoded by the TYMS gene …
[HTML][HTML] Tumor-associated monocytes promote mesenchymal transformation through EGFR signaling in glioma
The role of brain immune compartments in glioma evolution remains elusive. We profile
immune cells in glioma microenvironment and the matched peripheral blood from 11 …
immune cells in glioma microenvironment and the matched peripheral blood from 11 …
Single-cell chromatin accessibility analysis reveals the epigenetic basis and signature transcription factors for the molecular subtypes of colorectal cancers
Z Liu, Y Hu, H Xie, K Chen, L Wen, W Fu, X Zhou… - Cancer Discovery, 2024 - AACR
Colorectal cancer is a highly heterogeneous disease, with well-characterized subtypes
based on genome, DNA methylome, and transcriptome signatures. To chart the epigenetic …
based on genome, DNA methylome, and transcriptome signatures. To chart the epigenetic …
[HTML][HTML] Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma
Q Zhu, Y Chai, L Jin, Y Ma, H Lu, Y Chen, W Feng - Scientific Reports, 2023 - nature.com
Lung adenocarcinoma (LUAD) remains an incurable disease with a poor prognosis. This
study aimed to explore neutrophil‑related genes (NRGs) and develop a prognostic signature …
study aimed to explore neutrophil‑related genes (NRGs) and develop a prognostic signature …